Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-059651
Filing Date
2021-10-05
Accepted
2021-10-05 18:16:20
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9723
  Complete submission text file 0001209191-21-059651.txt   11129
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

EIN.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POSEIDA THERAPEUTICS, INC. 4242 CAMPUS POINT COURT, SUITE 700 SAN DIEGO CA 92121
Business Address
Ostertag Eric (Reporting) CIK: 0001765987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 211308111